NYU Langone Medical Center Expands Gastrointestinal Malignancies Team
Renowned Medical Oncologists Lawrence and Gail Leichman Join Division of Hematology and Medical Oncology
Lawrence Leichman, MD and Cynthia Gail Leichman, MD, have been appointed faculty members of the Department of Medicine, Division of Hematology and Medical Oncology at NYU Langone Medical Center. They will specialize in GI cancer that include: esophagus, gastric, pancreas, liver, bile duct, carcinoid or neuroendocrine tumors of the small bowel, colon cancer, rectal cancer and cancer of the anal canal. They will have offices at the medical center’s Clinical Cancer Center at 160 E. 34th Street.
“We are extremely excited to welcome Drs. Lawrence and Gail Leichman to the NYU Langone Medical Center family,” said Andrew Brotman, MD, senior vice president, vice dean for clinical affairs and strategy, and chief clinical officer at NYU Langone. “The Leichmans are recognized leaders in the field of gastrointestinal malignancies and their clinical and research expertise in this area will continue to build on the world-class care our patients have already come to expect from us.”
Dr. Lawrence Leichman will serve at director, GI (Gastrointestinal) Malignancies in the Division of Hematology and Oncology. In this role he will focus on expanding the clinical and research areas of the Gastrointestinal Malignancies program. He most recently served as national director of Gastrointestinal Malignancies at Aptium Oncology and was affiliated with the Comprehensive Cancer Center at Desert Regional Medical Center in Palm Springs, CA. He is a researcher and a member of the National Cancer Institute’s Task Force for Esophageal and Gastric Cancer as well as an active member of the CORE Science Solutions (CSS) GI Cancer Consortium. Dr. Leichman received his MD from Wayne State University School of Medicine in Michigan.
Dr. Gail Leichman, will be a member of the Gastrointestinal Malignancies team. Dr. Leichman was the medical director for Clinical Research at the Comprehensive Cancer Center at Desert Regional Medical Center, Palm Springs, CA prior to joining NYU Langone. She served as a member of the Governing Board of Desert Regional Medical Center and is a member of the Intergroup Rectal Cancer Task Force and a member of the National Cancer Institute’s Task Force for Esophageal and Gastric Cancer. Dr. Leichman also received her MD from Wayne State University School of Medicine, Michigan.
The Leichman’s join a seasoned team of gastrointestinal cancer experts who evaluate and treat patients at the Clinical Cancer Center (CCC), a collaborative, multidisciplinary outpatient setting. The CCC is the clinical arm of the medical center’s NYU Cancer Institute, an NCI-designated cancer center, where patients can have physician appointments, undergo diagnostic tests, learn the results of those tests, and receive a personalized treatment plan-all under the same roof. The clinicians at the CCC also collaborate with researchers conducting basic science research related to gastrointestinal cancers, and use this research to develop novel treatment strategies which are evaluated in clinical trials.